196 related articles for article (PubMed ID: 33338727)
1. Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis.
Park S; Nam CM; Kim SG; Mun JE; Rha SY; Chung HC
Eur J Cancer; 2021 Feb; 144():49-60. PubMed ID: 33338727
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Efficacy and Safety of Third-Line Treatments for Advanced Gastric Cancer: A Systematic Review With Bayesian Network Meta-Analysis.
Huang M; Li J; Yu X; Xu Q; Zhang X; Dai X; Li S; Sheng L; Huang K; Liu L
Front Oncol; 2021; 11():734323. PubMed ID: 34745955
[TBL] [Abstract][Full Text] [Related]
3. A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma.
Franken MG; Leeneman B; Gheorghe M; Uyl-de Groot CA; Haanen JBAG; van Baal PHM
Eur J Cancer; 2019 Dec; 123():58-71. PubMed ID: 31670077
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and tolerability of first-line treatments for untreated, HER2-negative, advanced gastric cancer: systematic review and network meta-analysis.
Cai T; Liang L; Zhao X; Lin C; Li D; Zheng J
Crit Rev Oncol Hematol; 2024 Jan; 193():104216. PubMed ID: 38029945
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials.
Zhao TT; Xu H; Xu HM; Wang ZN; Xu YY; Song YX; Yin SC; Liu XY; Miao ZF
Gastric Cancer; 2018 May; 21(3):361-371. PubMed ID: 29455269
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety of third-line treatments for advanced gastric cancer: A systematic review and network meta-analysis.
Zhang C; Xiang Y; Wang J; Yan D
Front Oncol; 2023; 13():1118820. PubMed ID: 36937403
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian network meta-analysis on systemic therapy for previously treated gastric cancer.
Kim JH; Zang DY; Jang HJ; Kim HS
Crit Rev Oncol Hematol; 2021 Nov; 167():103505. PubMed ID: 34656747
[TBL] [Abstract][Full Text] [Related]
8. Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Cancer: a Bayesian Network Meta-Analysis.
Zhu L; Liu J; Ma S
Pathol Oncol Res; 2016 Oct; 22(4):853-61. PubMed ID: 27236591
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of targeted drugs in advanced or metastatic gastric and gastroesophageal junction cancer: A network meta-analysis.
Gong H; Su Y; Zhao L; Ma L; Zhang L; Hou L; Li T; Niu S; Zhang H; Li C; Jin X; Ge L; Leng G; Liu Y
J Clin Pharm Ther; 2022 Apr; 47(4):493-506. PubMed ID: 34796971
[TBL] [Abstract][Full Text] [Related]
10. Network meta-analysis of nivolumab plus ipilimumab in the second-line setting for advanced hepatocellular carcinoma.
Parikh ND; Marshall A; Betts KA; Song J; Zhao J; Yuan M; Wu A; Huff KD; Kim R
J Comp Eff Res; 2021 Apr; 10(5):343-352. PubMed ID: 33442996
[No Abstract] [Full Text] [Related]
11. PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: A network meta-analysis.
Guo X; Yang B; He L; Sun Y; Song Y; Qu X
Front Immunol; 2022; 13():905651. PubMed ID: 36003374
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer: a Bayesian network meta-analysis.
Liu S; Wong HY; Xie L; Kim Y; Shu D; Zheng B; Liu N; Xing C; Chen X; Dong Q
Sci Rep; 2022 Dec; 12(1):22024. PubMed ID: 36539429
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis.
Toor K; Middleton MR; Chan K; Amadi A; Moshyk A; Kotapati S
BMC Cancer; 2021 Jan; 21(1):3. PubMed ID: 33402121
[TBL] [Abstract][Full Text] [Related]
14. A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis.
Guo X; Zhao F; Ma X; Shen G; Ren D; Zheng F; Du F; Wang Z; Ahmad R; Yuan X; Zhao J; Zhao J
BMC Cancer; 2019 Nov; 19(1):1125. PubMed ID: 31747911
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer.
Sonbol MB; Benkhadra R; Wang Z; Firwana B; Walden DJ; Mody K; Hubbard JM; Murad MH; Ahn DH; Bekaii-Saab T
Oncologist; 2019 Sep; 24(9):1174-1179. PubMed ID: 31164455
[TBL] [Abstract][Full Text] [Related]
16. A Bayesian network meta-analysis on second-line systemic therapy in advanced gastric cancer.
Zhu X; Ko YJ; Berry S; Shah K; Lee E; Chan K
Gastric Cancer; 2017 Jul; 20(4):646-654. PubMed ID: 27722826
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis.
Créquit P; Chaimani A; Yavchitz A; Attiche N; Cadranel J; Trinquart L; Ravaud P
BMC Med; 2017 Oct; 15(1):193. PubMed ID: 29082855
[TBL] [Abstract][Full Text] [Related]
18. Doublet Versus Single Agent as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis of 10 Randomized Controlled Trials.
Zhang Y; Ma B; Huang XT; Li YS; Wang Y; Liu ZL
Medicine (Baltimore); 2016 Feb; 95(8):e2792. PubMed ID: 26937908
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: A systematic review and meta-analysis of randomized controlled trials.
Hao C; Tian J; Liu H; Li F; Niu H; Zhu B
Medicine (Baltimore); 2017 Jun; 96(26):e7325. PubMed ID: 28658143
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis.
Wang L; Li J; Chen H
Chemotherapy; 2024; 69(1):11-22. PubMed ID: 37339610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
